ProtoKinetix' AAGP(TM) More Than Doubles Stem Cell Recovery
Print article
Refer to a friend
© Business Wire 2008
2008-01-23 08:15:36 -
- Research in the field of stem cell therapy has exploded over the
last few years. Stem cells are immature, unprogrammed cells that have
the ability to grow into different kinds of tissue. Recent studies
have shown that stem cell therapies offer real hope for the treatment
of a wide range of diseases such as leukemia, diabetes, spinal cord
injury,
heart damage, brain damage, blood cell formation and even hair loss.
As a result of current findings, major initiatives are being
conducted by large pharmaceutical and biotechnology companies,
research establishments and universities around the world, to develop
stem cell therapies in regenerative medicine. Unfortunately the
demand for stem cells outstrips the supply. One of the bottlenecks in
this rapidly expanding industry and ultimate commercialization is the
ability to deliver sufficient supply of stem cells to advance these
programs. Currently there are a vast number of stem cells lost in the
process of cultivation, storage, transportation and recovery from
cryopreservation.
ProtoKinetix (OTCBB:PKTX) reports that repeated tests have confirmed
that the addition of AAGP(TM) to the cryopreservation process more
than doubles the useable inventory of these very delicate and
valuable cells.
About ProtoKinetix
ProtoKinetix Inc is a biotechnology company that has developed and
patented a family of synthetic anti-aging glycoproteins (AAGP(TM))
for medicine and the biotechnology and cosmetic industries. PKTX is
currently in dialogue with major corporations and institutions who
have contacted the company about the broad range of applications for
AAGP(TM) products.
For more detailed information, please visit our new website at:
www.protokinetix.
The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" for forward-looking statements. Some information included in
this press release contains statements that are forward-looking. Such
forward-looking information involves significant risks and
uncertainties that could affect anticipated results in the future
and, accordingly, these results may differ materially from those
expressed in any forward-looking statements made by or on behalf of
the Company. For a description of additional risks and uncertainties,
please refer to the Company's filings with the Securities and
Exchange Commission. -0- Company Office Ross L. Senior, LLB -
President and CEO Suite # 1500 885 West Georgia Street Vancouver, BC
V6C 3E8
Investor Contact
ProtoKinetix Inc.
Blair Henderson, 604-687-9887
http://www.pr-
r399390.htm
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:
Children's Neurobiological Solutions
http://www.CNSfoundation.org/
Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123
The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Earn your degree in as few as 2 years - Advance your career with an AS, BS, MS degree - College-Finder.net.
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___
